// June 21, 2023
Protecting patients from substandard and falsified medicines through post-marketing surveillance
Substandard and falsified (SF) medical products remain one of the most significant public health
Substandard and falsified (SF) medical products remain one of the most significant public health
Quality assurance is a wide-ranging concept encompassing all factors that collectively influence
When it comes to good distribution practices (GDPs) for medical products, patient safety is the h
Over the past three years, the COVID-19 pandemic made long-standing medical product supply chain